Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)

Elanco Animal Health (ELAN) reported Asset Writedowns and Impairment of $47.0 million for Q4 2025, up 840.0% on a YoY basis from $5.0 million in Q4 2024, and up 95.83% sequentially from $24.0 million in Q3 2025.

Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends

Elanco Animal Health (ELAN) has 9 years of Asset Writedowns and Impairment data on file, last reported at $47.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 840.0% year-over-year to $47.0 million; the trailing twelve-month figure through Dec 2025 stood at $91.0 million (up 75.0% YoY), and the FY2025 full-year result was $71.0 million, down 12.35% from the prior year.
  • Asset Writedowns and Impairment grew to $47.0 million in Q4 2025, from $24.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $275.0 million in Q2 2021 to a low of $5.0 million in Q4 2021.
  • A 5-year average of $45.8 million and a median of $23.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
  • Across the five-year window, Asset Writedowns and Impairment surged 9066.67% in 2021 and plunged 81.48% in 2024, its largest moves.
  • Tracing ELAN's Asset Writedowns and Impairment over 5 years: stood at $5.0 million in 2021, then surged by 1080.0% to $59.0 million in 2022, then tumbled by 54.24% to $27.0 million in 2023, then plunged by 81.48% to $5.0 million in 2024, then soared by 840.0% to $47.0 million in 2025.
  • Business Quant data shows ELAN's Asset Writedowns and Impairment at $47.0 million in Q4 2025, $24.0 million in Q3 2025, and $5.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 24.00 Mn
Sep 30, 2025 24.00 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 15.00 Mn
Sep 30, 2024 15.00 Mn
Dec 31, 2023 27.00 Mn
Dec 31, 2023 27.00 Mn
Sep 30, 2023 5.00 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2022 59.00 Mn
Jun 30, 2022 59.00 Mn
Mar 31, 2022 22.00 Mn
Mar 31, 2022 22.00 Mn
Dec 31, 2021 5.00 Mn
Dec 31, 2021 5.00 Mn
Sep 30, 2021 56.00 Mn
Sep 30, 2021 56.00 Mn